Bortezomib as a rescue therapy for hyperacute and multi-drug resistant mixed acute rejection after kidney transplantation.

Arjang Djamali, Brenda L. Muth, Jose Torrealba, Debra Bloom, Karen M. Miller, David Lorentzen, Hans W. Sollinger, John D. Pirsch, Joshua D. Mezrich